UBS upgraded ResMed (RMD) to Buy from Neutral with a price target of $290, up from $255. The firm thinks consensus is too cautious in the ...

Apple (AAPL) reported December quarter revenue above expectations driven by modestly better iPhone revenue, and provided limited March ...

Nisa Investment Advisors LLC cut its holdings in shares of Paramount Group, Inc. (NYSE:PGRE – Free Report) by 10.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC.